Stockreport

Spero Therapeutics to advance antibiotic candidate SPR994 at 2x higher dose; shares up 11% after hours [Seeking Alpha]

Spero Therapeutics, Inc.  (SPRO) 
Last spero therapeutics, inc. earnings: 3/16 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: investors.sperotherapeutics.com/overview
PDF Spero Therapeutics to advance antibiotic candidate SPR994 at 2x higher dose; shares up 11% after hours [Read more]